AzTrials
AzTrials

Hearing Loss, Bilateral or UnilateralSCEDuLLNCT07028658

Effectiveness of Speech Therapy for Lip-reading in Patients With Hearing Aids: SCED Study

An observational study of Hearing Loss, Bilateral or Unilateral, run by Institut Pasteur at 1 site in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study aims to investigate whether lip reading rehabilitation improves viseme recognition in individuals with hearing impairments who use hearing aids. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Hearing Loss, Bilateral or Unilateral
What is being tested?
Speechreading training
How many people
8 participants
Where
1 siteFrance
Study dates
16 Oct 2025to Sep 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The study population consists of hearing-impaired individuals with hearing aids

Who may be able to join

  • Patient aged 18 or older
  • Affiliated with a social security system
  • Moderate to severe bilateral post-lingual hearing loss, fitted with hearing aids for more than 6 months
  • Wearing hearing aids for a minimum of 8 hours/day on average over the past month
  • Intelligibility in quiet > 80% correct responses at 60 dB (Lafon cochlear list)
  • Difficulty in noisy environments rated > 6 on a 0-10 EVA scale
  • French language comprehension level of at least B1 CEFR (Common European Framework of Reference for Languages)
  • Willing to participate in speech therapy rehabilitation at a rate of 2 sessions per week

Who cannot join

  • Patient who has already undergone speech therapy rehabilitation as part of their hearing loss treatment
  • Diagnosis of neurodegenerative disease or history of brain injury (traumatic brain injury, stroke, tumor, meningitis, etc.)
  • Uncorrected vision or visual impairment affecting lip reading (e.g. AMD, glaucoma, unoperated cataract, etc.)
  • Presence of severe tinnitus (score > 56) on the Tinnitus Handicap Inventory (THI) questionnaire
  • Significant cognitive impairment (CODEX C or D) or Montreal Cognitive Assessment (MOCA) score < 23

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

France1 site, 1 recruiting
  • Cabinet d'orthophonie

    Paris, 75008

    Aurensan, +33986301929, orthophoniste.roxane@gmail.com

    Recruiting

Other trials in France

About this study

Official title: Efficacité de la rééducation Orthophonique de la Lecture Labiale Des Patients appareillés Auditifs : étude SCED

This study aims to investigate whether lip reading rehabilitation improves viseme recognition in individuals with hearing impairments who use hearing aids.

Being tested
Speechreading training
Medical subject headings
Hearing Loss

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Speechreading trainingOther

    The patient will undergo 16 lip reading training sessions. By developing functional lip reading skills, they will be able to fill in the gaps in auditory information they miss, especially in loud or noisy settings

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Repetition score, in words (with and without labial doppelganger) of Lafon's cochlear lists presented on video support in visual-only modality

    Measured: 26 sessions (4,5 months)

  2. Repetition score, in visemes (with and without labial doppelganger) of Lafon's cochlear lists presented on video support in visual-only modality

    Measured: 26 sessions (4,5 months)

Secondary outcomes (4)
  1. Repetition score of 10 non-words on recorded support with a Signal-to-Noise Ratio of 10

    Measured: 26 sessions (4,5 months)

  2. Repetition score of sentences on video support in audiovisual modality

    Measured: 26 sessions (4,5 months)

  3. Identification score of two sequences of musical notes

    Measured: 26 sessions (4,5 months)

  4. Impact of speech therapy rehabilitation on quality of life

    AVS from 0 to 10

    Measured: 26 sessions (4,5 months)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Jun 2025
  2. Study start16 Oct 2025
  3. Primary completionSep 2026 (estimated)
  4. Study completionSep 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
8 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07028658
Sponsor's protocol ID
2024-135_SCEDuLL
Other IDs
2025-A00506-23
Acronym
SCEDuLL
Status last verified
Dec 2025
First submitted
11 Jun 2025
Last updated
3 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Hearing Loss, Bilateral or Unilateral, run by Institut Pasteur at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 3 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Repetition score, in words (with and without labial doppelganger) of Lafon's cochlear lists presented on video support in visual-only modality (time frame: 26 sessions (4,5 months)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Apr 2026; AzTrials last refreshed its copy on 26 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in